Source: ALL
| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1,4-alpha-glucan branching enzyme 1 | 0.612 | 0.654 | 1.1E-12 |
|
disease | 0.300 | limited | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
2,4-dienoyl-CoA reductase 1 | 0.426 | 0.885 | 4.5E-14 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
3-hydroxybutyrate dehydrogenase 1 | 0.729 | 0.423 | 7.6E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | |||||||||
|
absent in melanoma 2 | 0.521 | 0.769 | 2.2E-09 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
acetyl-CoA carboxylase alpha | 0.480 | 0.846 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
actin alpha 2, smooth muscle | 0.508 | 0.846 | 0.93 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2005 | 2005 | ||||||||
|
actin alpha cardiac muscle 1 | 0.610 | 0.538 | 0.74 |
|
disease | 0.370 | None | 1.000 | 7 | 1 | 1998 | 2019 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.100 | None | 0.882 | 17 | 0 | 1997 | 2020 | ||||||||
|
actin binding Rho activating protein | 1.000 | 0.038 | 6.2E-06 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
actinin alpha 2 | 0.686 | 0.462 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
activating transcription factor 1 | 0.588 | 0.577 | 0.63 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
activating transcription factor 6 | 0.516 | 0.846 | 3.2E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
activin A receptor type 1C | 0.700 | 0.423 | 8.5E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
ADAM metallopeptidase domain 10 | 0.489 | 0.846 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
ADAM metallopeptidase domain 17 | 0.453 | 0.808 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
ADAM metallopeptidase domain 33 | 0.636 | 0.423 | 2.1E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 18 | 0.636 | 0.654 | 1.1E-29 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 20 | 0.760 | 0.385 | 4.5E-38 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 8 | 0.674 | 0.346 | 1.2E-10 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
ADAMTS9 antisense RNA 2 | 0.656 | 0.462 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
adenosine A2a receptor | 0.526 | 0.769 | 0.60 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
adenosine monophosphate deaminase 1 | 0.573 | 0.692 | 1.9E-21 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2010 | 2019 | ||||||||
|
adrenoceptor beta 1 | 0.555 | 0.769 | 2.9E-06 |
|
disease | 0.400 | None | 1.000 | 11 | 2 | 1998 | 2019 |